ADIPOQ and atherosclerosis: Longitudinal studies are also warranted to confirm whether plasma omentin levels are predictive of the progression of atherosclerosis in T2D patients with increased plasma adiponectin levels, e.g., non-obese older adults or those with chronic kidney disease.